Inger von Bultzingslowen
Overview
Explore the profile of Inger von Bultzingslowen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mougeot J, Beckman M, Alexander A, Hovan A, Hasseus B, Legert K, et al.
Support Care Cancer
. 2024 Mar;
32(4):220.
PMID: 38467943
Purpose: Leukemias have been associated with oral manifestations, reflecting susceptibility to cancer therapy-induced oral mucositis. We sought to identify SNPs associated with both leukemia and oral mucositis (OM). Methods: Whole...
2.
Bulthuis M, van Leeuwen S, Thomas R, van Gennip L, Whiteside H, Isom S, et al.
Transplant Cell Ther
. 2024 Jan;
30(4):446.e1-446.e11.
PMID: 38242439
Xerostomia, or subjective oral dryness, is a serious complaint after hematopoietic cell transplantation (HCT). Xerostomia is rated as one of the most bothersome symptoms by HCT recipients, negatively affecting quality...
3.
Agholme M, Dahllof G, Torlen J, Majorana A, Brennan M, von Bultzingslowen I, et al.
Support Care Cancer
. 2023 Nov;
31(12):702.
PMID: 37971651
Purpose: Oral mucositis is a common complication for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and causes pain and difficulties in functions like eating and swallowing, resulting in lower...
4.
Bulthuis M, van Gennip L, Thomas R, Bronkhorst E, Laheij A, Raber-Durlacher J, et al.
Clin Oral Investig
. 2023 Oct;
27(12):7369-7381.
PMID: 37853264
Objectives: Haematopoietic cell transplantation (HCT) preceded by a conditioning regimen is an established treatment option for (non)malignant haematologic disorders. We aim to describe the development of hyposalivation over time in...
5.
Mougeot J, Beckman M, Hovan A, Hasseus B, Legert K, Johansson J, et al.
Support Care Cancer
. 2023 Sep;
31(10):587.
PMID: 37731134
Introduction: Chronic graft-versus-host disease (cGVHD) is a debilitating side effect of allogeneic hematopoietic cell transplantation (HCT), affecting the quality of life of patients. We used whole exome sequencing to identify...
6.
Skallsjo K, von Bultzingslowen I, Hasseus B, Johansson J, Ohman J, Raber-Durlacher J, et al.
PLoS One
. 2023 May;
18(5):e0285615.
PMID: 37200298
Despite advances in transplant medicine, prevalence of complications after hematopoietic stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors on the incidence and severity of complications...
7.
Bulthuis M, van Gennip L, Thomas R, Bronkhorst E, Laheij A, Raber-Durlacher J, et al.
Caries Res
. 2022 Jun;
56(3):187-196.
PMID: 35724637
Haematopoietic stem cell transplantation (HSCT) preceded by a conditioning regimen is an established treatment option for many haematological diseases. Decreased salivary flow rates after HSCT may increase caries risk. We...
8.
Laheij A, Rozema F, Brennan M, von Bultzingslowen I, van Leeuwen S, Potting C, et al.
Microorganisms
. 2022 Apr;
10(4).
PMID: 35456787
Stem cell transplantation (SCT) is associated with oral microbial dysbiosis. However, long-term longitudinal data are lacking. Therefore, this study aimed to longitudinally assess the oral microbiome in SCT patients and...
9.
Olsson J, Mattsson U, von Bultzingslowen I, Pettersson B, Warfvinge G, Ljunggren A
Acta Odontol Scand
. 2021 Jun;
80(1):29-37.
PMID: 34107238
Objective: To examine how hospital-affiliated dentists assess risk and evaluate oral foci of infection in patients facing certain medical treatments, and whether the nature of upcoming medical treatment affects the...
10.
Mougeot J, Beckman M, Stevens C, Almon K, Morton D, von Bultzingslowen I, et al.
J Oral Microbiol
. 2020 Jun;
12(1):1761135.
PMID: 32537095
Oral mucositis (OM) is a common side effect of conditioning therapy implemented before hematopoietic stem cell transplantation (HSCT). The role of oral microbiome in OM is not fully elucidated. To...